fullerene c60 has been researched along with Liver Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anraku, M; Hirayama, F; Iohara, D; Uekama, K; Umezaki, Y | 1 |
1 other study(ies) available for fullerene c60 and Liver Dysfunction
Article | Year |
---|---|
In Vitro and In Vivo Evaluation of Hydrophilic C60(OH)10/2-Hydroxypropyl-β-cyclodextrin Nanoparticles as an Antioxidant.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antioxidants; Cell Death; Free Radical Scavengers; Fullerenes; HeLa Cells; Hep G2 Cells; Humans; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Reactive Nitrogen Species | 2016 |